Gemina Laboratories Ltd.
GLABF
$0.05
-$0.02-27.54%
OTC PK
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.99% | -37.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -20.28% | -38.83% | |||
| Operating Income | 20.28% | 37.86% | |||
| Income Before Tax | 20.12% | 43.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.12% | 43.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.12% | 43.73% | |||
| EBIT | 20.28% | 37.86% | |||
| EBITDA | 20.35% | 38.00% | |||
| EPS Basic | 20.51% | 44.29% | |||
| Normalized Basic EPS | 20.00% | 43.18% | |||
| EPS Diluted | 20.51% | 44.29% | |||
| Normalized Diluted EPS | 20.00% | 43.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||